Used in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors, particularly targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in developing treatments for non-small cell lung cancer and other solid tumors due to its ability to cross the blood-brain barrier and inhibit mutant forms of EGFR. Also employed in studies focused on improving drug selectivity and reducing off-target effects in targeted cancer therapies.